| scholarly article | Q13442814 |
| P2093 | author name string | Anatol C Kreitzer | |
| Talia N Lerner | |||
| P2860 | cites work | Synaptic organisation of the basal ganglia | Q24544917 |
| Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids | Q24680497 | ||
| A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice | Q27324171 | ||
| Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain | Q28250219 | ||
| Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function | Q28261240 | ||
| Enzymatic pathways that regulate endocannabinoid signaling in the nervous system | Q28390932 | ||
| Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
| Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice | Q28513036 | ||
| Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice | Q28591248 | ||
| The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission | Q28594648 | ||
| The molecular logic of endocannabinoid signalling | Q29615356 | ||
| The role of the basal ganglia in habit formation | Q29619829 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Convergent evidence for abnormal striatal synaptic plasticity in dystonia | Q33756951 | ||
| A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation | Q33826228 | ||
| Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. | Q33857802 | ||
| Role of the basal ganglia in the control of purposive saccadic eye movements | Q33909385 | ||
| Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses | Q34100802 | ||
| Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins | Q34128004 | ||
| Learning and memory functions of the Basal Ganglia | Q34132332 | ||
| Pathophysiologic basis of surgery for Parkinson's disease. | Q34144980 | ||
| Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
| Circuits and circuit disorders of the basal ganglia | Q34599488 | ||
| Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling | Q34650334 | ||
| A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins | Q34960765 | ||
| Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses | Q36054269 | ||
| Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins | Q36267106 | ||
| Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease | Q36873486 | ||
| Striatal plasticity and basal ganglia circuit function | Q37336143 | ||
| Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection | Q37629163 | ||
| Neuromodulatory control of striatal plasticity and behavior. | Q37844744 | ||
| Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. | Q39353443 | ||
| The basal ganglia and adaptive motor control | Q40706589 | ||
| Potentiation of neuronal L calcium channels by IGF-1 requires phosphorylation of the alpha1 subunit on a specific tyrosine residue | Q40862278 | ||
| Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit | Q41090124 | ||
| Dopamine activation of endogenous cannabinoid signaling in dorsal striatum | Q41646203 | ||
| Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism | Q42464540 | ||
| Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. | Q42473820 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage | Q42512972 | ||
| Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning | Q42668061 | ||
| Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins | Q43736623 | ||
| Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion | Q44593845 | ||
| Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time | Q44847937 | ||
| Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. | Q44922297 | ||
| Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. | Q45119266 | ||
| Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice. | Q46003801 | ||
| Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 | ||
| Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. | Q46441823 | ||
| Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. | Q46624652 | ||
| Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission | Q46986845 | ||
| Chronic cocaine reduces RGS4 mRNA in rat prefrontal cortex and dorsal striatum | Q48104056 | ||
| Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. | Q48130770 | ||
| Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. | Q48217036 | ||
| Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. | Q48257640 | ||
| RGS4 inhibits signaling by group I metabotropic glutamate receptors. | Q48539239 | ||
| RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion | Q48540394 | ||
| Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms | Q48846656 | ||
| Functional coupling between ryanodine receptors and L-type calcium channels in neurons | Q48940555 | ||
| Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal | Q49124925 | ||
| Post-receptor mechanisms underlying striatal long-term depression. | Q51627778 | ||
| The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 | ||
| Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization | Q80785132 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dopamine | Q170304 | ||
| striatum | Q1319792 | ||
| P304 | page(s) | 347-359 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Neuron | Q3338676 |
| P1476 | title | RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits | |
| P478 | volume | 73 |
| Q52320595 | A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex. |
| Q28486540 | A high throughput screen for RGS proteins using steady state monitoring of free phosphate formation |
| Q47225379 | Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine |
| Q90205448 | An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19 |
| Q47885942 | Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. |
| Q41159357 | Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release |
| Q48231025 | Association between RGS4 variants and psychotic-like experiences in nonclinical individuals. |
| Q99619162 | Basal Ganglia-A Motion Perspective |
| Q36797226 | CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling |
| Q55252194 | Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. |
| Q38809530 | Chronic Nicotine Alters Corticostriatal Plasticity in the Striatopallidal Pathway Mediated By NR2B-Containing Silent Synapses |
| Q26824698 | Control of synaptic function by endocannabinoid-mediated retrograde signaling |
| Q39147170 | Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors |
| Q33575226 | Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons |
| Q38719872 | Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells |
| Q49821000 | Differential Protein Dynamics of Regulators of G-protein Signaling: Role in Specificity of Small-molecule Inhibitors. |
| Q98564856 | Dopamine D2 receptor signaling on iMSNs is required for initiation and vigor of learned actions |
| Q57295457 | Dopamine-endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum |
| Q92773981 | Dopaminergic modulation of striatal function and Parkinson's disease |
| Q38233462 | Dopaminergic modulation of striatal networks in health and Parkinson's disease |
| Q37310301 | Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions |
| Q58749186 | Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons |
| Q27304699 | Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization. |
| Q41557765 | Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices |
| Q38328775 | Embedded synaptic feedback in the neuroendocrine stress axis. |
| Q34304094 | Endocannabinoid signaling and synaptic function |
| Q47570978 | Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model |
| Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
| Q43832701 | Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex |
| Q33624983 | Endogenous cannabinoid signaling at inhibitory interneurons. |
| Q50200300 | Functional relevance of endocannabinoid-dependent synaptic plasticity in the CNS. |
| Q57178844 | Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease |
| Q40611076 | Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses |
| Q37686101 | Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling |
| Q42470816 | Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. |
| Q38203030 | Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction |
| Q90304563 | Interplay of cysteine exposure and global protein dynamics in small-molecule recognition by a regulator of G-protein signaling protein |
| Q52655473 | Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons. |
| Q28590820 | Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors |
| Q36892615 | M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia |
| Q37516434 | Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia |
| Q35132556 | Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. |
| Q88786315 | Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies |
| Q40989519 | Modification and functional inhibition of regulator of G-protein signaling 4 (RGS4) by 4-hydroxy-2-nonenal |
| Q38135783 | Molecular mechanisms underlying neuronal synaptic plasticity: systems biology meets computational neuroscience in the wilds of synaptic plasticity |
| Q88227478 | Molecular mechanisms underlying striatal synaptic plasticity: relevance to chronic alcohol consumption and seeking |
| Q45016723 | Multimodal Plasticity in Dorsal Striatum While Learning a Lateralized Navigation Task. |
| Q35829479 | Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release. |
| Q38280778 | Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses |
| Q42953640 | New twist on orphan receptor GPR88 function |
| Q64911660 | Parkinson's Disease-Linked LRRK2-G2019S Mutation Alters Synaptic Plasticity and Promotes Resilience to Chronic Social Stress in Young Adulthood. |
| Q48081087 | Plasticity in striatopallidal projection neurons mediates the acquisition of habitual actions. |
| Q35499568 | Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection |
| Q89517111 | RGS proteins as critical regulators of motor function and their implications in Parkinson's disease |
| Q37398369 | RGS17: an emerging therapeutic target for lung and prostate cancers |
| Q91900172 | RGS4 Maintains Chronic Pain Symptoms in Rodent Models |
| Q30541823 | Rab family proteins regulate the endosomal trafficking and function of RGS4. |
| Q47637709 | Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins |
| Q34961512 | Regulation of dendritic calcium release in striatal spiny projection neurons |
| Q38641769 | Regulator of G protein signaling 14 (RGS14) is expressed pre- and postsynaptically in neurons of hippocampus, basal ganglia, and amygdala of monkey and human brain |
| Q36855323 | Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models |
| Q34991036 | Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay |
| Q49834838 | Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior |
| Q36502948 | Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity |
| Q100694445 | SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells |
| Q36157798 | Sensing Positive versus Negative Reward Signals through Adenylyl Cyclase-Coupled GPCRs in Direct and Indirect Pathway Striatal Medium Spiny Neurons. |
| Q33816759 | Sensitivity to theta-burst timing permits LTP in dorsal striatal adult brain slice |
| Q34629089 | Signaling pathways involved in striatal synaptic plasticity are sensitive to temporal pattern and exhibit spatial specificity |
| Q47205128 | Specific Effects of Chronic Dietary Exposure to Chlorpyrifos on Brain Gene Expression-A Mouse Study. |
| Q28535422 | Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine |
| Q89326911 | Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity |
| Q50917064 | Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. |
| Q39414543 | Striatal cholinergic interneurons and Parkinson's disease. |
| Q48138673 | Striatal synapses, circuits, and Parkinson's disease |
| Q26829347 | Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia |
| Q41748040 | The GABAA receptor agonist muscimol induces an age- and region-dependent form of long-term depression in the mouse striatum. |
| Q57472868 | The effortless custody of automatism |
| Q30397640 | The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21. |
| Q35034305 | The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium |
| Q58090420 | Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders |
| Q37135312 | Voltage drives diverse endocannabinoid signals to mediate striatal microcircuit-specific plasticity. |
Search more.